February 28, 2015
Why is a payday loan right for you Payday loan 50 up to
Payday loans uk

Hep C & the War on Drugs

Posted on July 12, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl The War on Common Sense A new report advocates decriminalizing drug use to reduce Hep C The so-called “war on drugs” is creating an epidemic of hepatitis C. That’s the finding of a new report by the Global Commission on Drug Policy, which finds that drug war policies have caused [...]

Man to Man

Posted on May 29, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl For MSMs: treatment hope for HCV—and a warning There’s more evidence of the effectiveness of new antiretroviral drugs in treating the hepatitis C virus (HCV). This time it’s a study, presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in March in Atlanta, that showed adding telaprevir [...]

Blocking the Entrance

Posted on February 24, 2012 by in Hep Talk, LifeGuide

Entry inhibitors usher in a new phase of hep C research by Larry Buhl Future therapy for hepatitis C infection may include a variety of drugs working together to target the virus at multiple stages of its life cycle, according to a research team at the University of Illinois at Chicago College of Medicine, which [...]

Taking a Toll

Posted on February 4, 2012 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] Hep C is surpassing HIV as a deadlier disease by Larry Buhl There was a new milestone reached last month when a new study suggested that the number of deaths from chronic hepatitis C now exceed those from HIV-related illnesses. The study was released by the U.S. Centers for Disease Control and [...]

Red Flags

Posted on December 9, 2011 by in Hep Talk, LifeGuide, Noteworthy

LifeGuide [Hep Talk] African Americans face medical barriers to HCV treatment by Larry Buhl In the U.S. blacks are disproportionately infected with the hepatitis C virus (HCV), and are less likely to receive treatment for HCV than whites. Treatment barriers go beyond affordability and lack of access to care. A new study shows that, significantly, [...]

Step Up

Posted on November 15, 2011 by in Hep Talk, LifeGuide, Noteworthy

LifeGuide [Hep Talk] HCV testing targets baseball lovers by Larry Buhl This summer a pilot program was launched to raise awareness of the importance of testing for the hepatitis C virus (HCV). Step Up to the Plate Against Hepatitis C is a partnership between the American Liver Foundation (ALF), Merck, the Coalition on Positive Health Empowerment, [...]

Cutting Glass

Posted on October 17, 2011 by in Hep Talk, LifeGuide, Noteworthy

A study links anal sex & meth to increased HCV rates among MSMs by Larry Buhl LifeGuide [Hep Talk] For decades it has been the conventional wisdom that hepatitis C is transmitted primarily by exposure to blood containing the hepatitis C virus (HCV) and that transmission rarely occurs from exposure to other infected body fluids, [...]

Screen Time

Posted on August 24, 2011 by in Hep Talk, LifeGuide, Noteworthy

A new study indicates age-based screening can lower hepatitis c mortality by Larry Buhl LifeGuide [Hep Talk] It is well understood that early detection can prevent serious complications and death due to HCV, yet approximately three-quarters of Americans with HCV are not aware they are infected, and many will not be diagnosed until they are [...]

Coffee, Pot

Posted on August 2, 2011 by in Hep Talk, LifeGuide, Noteworthy

Can Caffeine and Cannabis Be Helpful for HCV and HIV? by Larry Buhl Doctors agree that lifestyle choices, such as food and substance intake, play a part in the progression (or improvement) of chronic diseases such as hepatitis and HIV. Caffeine, present in coffee, tea, chocolate, cola, and some over-the-counter medications, is metabolized through the [...]

Hurdles Cleared

Posted on June 28, 2011 by in Hep Talk, LifeGuide, Noteworthy

Approved by the fda, telaprevir and boceprevir usher in a new era of treatment by Larry Buhl The first breakthrough treatments for liver disease to be approved in twenty years are about to hit the market, giving new hope for the most difficult-to-treat patients with the hepatitis C virus (HCV). In May the FDA approved [...]